More recently, rare variants (<1% allele frequency) of larger effect size have also been identified as risk conferring (TREM2 0.3% [11], PLD3 < 0.5% [12], MAPT 0.3% [13]) or protective against (APP 0.01% [14] to 0.62% [15]) AD. This evidence concerns the gene APP and Alzheimer disease.